See important safety information, including boxed warning Austedo is used to treat the involuntary movements of huntington's disease and tardive dyskinesia (td) Includes austedo side effects, dosage, uses, interactions, and more In a cohort of 27 participants, up to 77% reported enhancements in daily activities such as speech and eating after three months of treatment Furthermore, 85% of those on austedo. Depression and suicidality in patients with huntington’s disease austedo xr and austedo can increase the risk of depression and suicidal thoughts and behavior (suicidality) in patients with huntington’s disease
Anyone considering the use of austedo xr or austedo must balance the risks of depression and suicidality with the clinical need for treatment. Tardive dyskinesia (td) emerges as a complex movement disorder often linked to prolonged neuroleptic or antipsychotic medication use While newer antipsychotics like aripiprazole offer reduced risk, managing td requires a careful review of treatments Austedo, with the generic name deutetrabenazine, is a medication specifically designed for managing movement disorders such as chorea associated with huntington's disease and tardive dyskinesia Many individuals facing these disorders often seek information on treatment options that can improve their quality of life This article aims to demystify austedo treatment by exploring its mechanism.
WATCH
